Generative AI Drugs Are Coming

The merging of deep, quality data and expertise with increasingly sophisticated AI capabilities has the potential to truly shift the future of medicine. 

Related Keywords

,Ian Goodfellow ,Aleksej Zelezniak ,Fosun Pharma ,Novartis ,Forbes Technology Council ,Generative Adversarial Networks ,National Human Genome Research Institute ,Astrazeneca ,Molecular Diversity ,National Human Genome Research ,Clinical Pharmacology ,Associate Professor Aleksej Zelezniak ,Drug Target ,Insilico Medicine ,Technology Council ,Steve Nouri ,